Welcome to english.eastday.com.Today is
Follow us @
Contribute to us!

Latest

Shanghai

Business

Culture

China

World

Pictures

Topics

Life

Services

Home >> auto >> Article
Hungary reports new daily record of 3,989 COVID-19 cases
From:Xinhua  |  2020-11-03 20:07

Video PlayerClose

BUDAPEST, Nov. 3 (Xinhua) -- Hungary registered 3,989 new COVID-19 cases on Tuesday, a fresh daily record since the outbreak of the epidemic in the country, according to the government's coronavirus information website.

Figures from the website showed that the total number of confirmed cases in Hungary stood at 86,769 on Tuesday, with 20,856 recoveries and 1,973 fatalities. Currently, 4,767 COVID-19 patients are being treated in hospital, 348 of them on ventilators.

The previous daily record of new COVID-19 cases was registered on Oct. 31, when Hungary added 3,908 cases in 24 hours.

The Hungarian government is set to adopt new and stricter anti-virus measures. "The government will hold a two-day government meeting this week, where there will be decisions on further tightening measures, as it is obvious that the current measures are not enough," Gergely Gulyas, head of the Prime Minister's Office, said on Monday.

Hungary's COVID-19 case count has risen sharply since late August. The country's caseload topped 10,000 on Sept. 10, 20,000 on Sept. 23, 30,000 on Oct. 4, 40,000 on Oct. 14, 50,000 on Oct. 21, 60,000 on Oct. 26, 70,000 on Oct. 30 and 80,000 on Nov. 2.

Hungarian Prime Minister Viktor Orban has pledged to procure COVID-19 vaccines, which will be made available to all citizens who want it.

Orban has said that his administration was engaged in talks on purchasing vaccines from China and Russia, adding that Hungary could have access to 2-3 different vaccines in the spring.

As the world is struggling to contain the pandemic, many countries are racing to find a vaccine. According to the website of the World Health Organization, as of Oct. 29, there were 201 COVID-19 candidate vaccines being developed worldwide, and 45 of them were in clinical trials. Enditem

Share